<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(8)</volume><submitter>Chen YY</submitter><pubmed_abstract>Astaxanthin extracted from Pomacea canaliculata eggs was made into free-form astaxanthin powder (FFAP) and its effects on lipid metabolism, liver function, antioxidants activities and astaxanthin absorption rate were investigated. 45 hamsters were split into 5 groups and fed with normal diet, high-cholesterol control (0.2% cholesterol), 1.6FFAP (control+1.6% FFAP), 3.2FFAP (control+3.2% FFAP) and 8.0FFAP (control+8.0% FFAP), respectively, for 6 weeks. FFAP diets significantly decreased the liver total cholesterol, triglyceride levels and increased liver fatty acids (C20:5n3; C22:6n3) compositions. It decreased plasma alanine aminotransferase and aspartate aminotransferase. In terms of anti-oxidative activities, we found 8.0 FFAP diet significantly decreased plasma and liver malonaldehyde (</pubmed_abstract><journal>PloS one</journal><pagination>e0134733</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4532504</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>In Vivo Effects of Free Form Astaxanthin Powder on Anti-Oxidation and Lipid Metabolism with High-Cholesterol Diet.</pubmed_title><pmcid>PMC4532504</pmcid><pubmed_authors>Liu LY</pubmed_authors><pubmed_authors>Chen YY</pubmed_authors><pubmed_authors>Lee PC</pubmed_authors><pubmed_authors>Wu YL</pubmed_authors></additional><is_claimable>false</is_claimable><name>In Vivo Effects of Free Form Astaxanthin Powder on Anti-Oxidation and Lipid Metabolism with High-Cholesterol Diet.</name><description>Astaxanthin extracted from Pomacea canaliculata eggs was made into free-form astaxanthin powder (FFAP) and its effects on lipid metabolism, liver function, antioxidants activities and astaxanthin absorption rate were investigated. 45 hamsters were split into 5 groups and fed with normal diet, high-cholesterol control (0.2% cholesterol), 1.6FFAP (control+1.6% FFAP), 3.2FFAP (control+3.2% FFAP) and 8.0FFAP (control+8.0% FFAP), respectively, for 6 weeks. FFAP diets significantly decreased the liver total cholesterol, triglyceride levels and increased liver fatty acids (C20:5n3; C22:6n3) compositions. It decreased plasma alanine aminotransferase and aspartate aminotransferase. In terms of anti-oxidative activities, we found 8.0 FFAP diet significantly decreased plasma and liver malonaldehyde (</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2025-04-18T21:38:54.759Z</modification><creation>2019-03-26T23:35:20Z</creation></dates><accession>S-EPMC4532504</accession><cross_references><pubmed>26262684</pubmed><doi>10.1371/journal.pone.0134733</doi></cross_references></HashMap>